Find your path to Daniel
15 people in our graph share verified history with Daniel — schools, employers, funds. One of them is your warm intro.
D.A. WallachunlockedDaniel: together at Time BioVentures
×11Daniel: together at Time BioVentures
About
Daniel Vasella, M.D., is Chairman of the Board of Numab Therapeutics AG, having joined the board in 2019 and become Chairman in 2020. He previously served as Chairman of Novartis AG from 1999 to 2013 and as its CEO from 1996 to 2010, and earlier held CEO and senior development and marketing roles at Sandoz Pharma. He earned an M.D. from the University of Bern in 1980 and completed studies at Harvard Business School.
Invests in
Biotech
Experience
- POP DüsseldorfFaculty Membercurrent2016 — present
- Numab Therapeutics AGChairman Of The Board2020 — 2023Schlieren, Zurich, Switzerland
- NovartisChairman1999 — 2013
- Novartis AGCEO1996 — 2010
Skills & more
Pharmaceutical Industry55Clinical Development29Oncology13Clinical Trials9Biotechnology15Pharmaceutical Sales16Drug Development29Lifesciences8Regulatory Affairs8Drug Discovery13Sales Effectiveness12Technology Transfer7
+4 more
Market AccessCardiologyDiabetesLife SciencesLanguages English · French · German
From Daniel's professional profile.
Investments
Board seats
American Express CompanyNumab Therapeutics AGPepsiCoSciClone Pharmaceuticals
Per the firm's website.
Colleagues at Time BioVentures
Bradford Cornell
Advisor at Time BioVentures
D.A. Wallach
General Partner at Time BioVentures
Jay Flatley
Advisor at Time BioVentures
Jim Allison, Ph.D.
Scientific Advisor at Time BioVentures
Leonard Schaeffer
Advisor at Time BioVentures
Pam Sharma, M.D., Ph.D.
Scientific Advisor at Time BioVentures
Paul McEwan
Scientific Advisor at Time BioVentures
Peter Attia, M.D.
Scientific Advisor at Time BioVentures
Frequently asked questions
- Who is Daniel L. Vasella, M.D.?
- Daniel Vasella, M.D., is Chairman of the Board of Numab Therapeutics AG, having joined the board in 2019 and become Chairman in 2020. He previously served as Chairman of Novartis AG from 1999 to 2013 and as its CEO from 1996 to 2010, and earlier held CEO and senior development and marketing roles at Sandoz Pharma. He earned an M.D. from the University of Bern in 1980 and completed studies at Harvard Business School.
- Where does Daniel L. Vasella, M.D. work?
- Daniel L. Vasella, M.D. is Advisor at Time BioVentures.
- What does Daniel L. Vasella, M.D. invest in?
- Daniel L. Vasella, M.D. invests in Biotech.
- What boards does Daniel L. Vasella, M.D. sit on?
- Daniel L. Vasella, M.D. holds tracked board seats at American Express Company, Numab Therapeutics AG, PepsiCo, SciClone Pharmaceuticals.
- Where did Daniel L. Vasella, M.D. go to school?
- Daniel L. Vasella, M.D. studied at University of Bern and University of Fribourg (Doctor of Medicine (M.D.)).
Shared employers
Also worked at Numab Therapeutics AG2
Also worked at Novartis201
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 195 more